Skip to content

Effect of combining Yoga therapy with Pelvic muscle training to treat inability to hold urine in women on outdoor basis.

Effect of Medical Yoga therapy along with Pelvic Floor Muscle Training (PFMT) for Stress Urinary Incontinence (SUI) women attending tertiary care hospital OPD, West Bengal. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068688
Enrollment
200
Registered
2024-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N393- Stress incontinence (female) (male)

Interventions

Intervention1: Medical Yoga therapy along with Pelvic Floor Muscle Training (PFMT): Medical yoga: A set of unique 21 postures, one day (60 min duration) per week directly supervised session for 8 week

Sponsors

Mala Bhowmik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Ambulatory women with the age group between 18 yrs to 60 yrs. ii. History of involuntary loss of urine for at least 3 months that is a social or hygienic problem. iii. Documented for minimum 3 episodes of incontinence on a screening 3-day voiding diary. iv. Participants also agreed to be refrain from other treatment related to incontinence during the trial period. v. Positive cough stress test. vi. Women residing within 100 km in radius. vii. History of stress urinary incontinence according to International Continence Society (ICS). viii. Urine leakage >4gm measured by pad test with standardized bladder volume. ix. Willing to give consent for participation in study. They must be motivated to undertake yoga exercises if required. x. Understands English/Hindi/Bengali.

Exclusion criteria

Exclusion criteria: The women will be excluded if they, I. Severe mobility limitation that would prevent from participating in yoga session. Eg. Inability to walk two blocks on level ground or unassisted getting up from supine to standing position within 10 seconds or inability to walk up a single stair. II. Participants did not use practitioner-supervised pharmacological or clinical treatments for last 3 months. III. Woman with UI having any of the following symptom’s pain or hematuria (assessed by urine dipstick testing), recurrent infections, interstitial cystitis or chronic pelvic pain, suspected or proven voiding problems, or significant pelvic organ prolapse. IV. Abnormal bladder function (residual urine >50 ml and maximal uroflow V. Women who had delivered a baby in last 6 months. VI. Women suffering from pelvic malignancy, h/o radical surgery and/or irradiation or anti-incontinent surgery/urethral surgery/or pelvic surgery. VII. Those taking diuretics and/or excessive caffeine. VIII. Women with neurological or psychiatric disorders, uncontrolled diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Average frequency of stress urinary incontinence episodes using validated 3-days voiding diary.Timepoint: Baseline, 4 weeks, 8 weeks.

Secondary

MeasureTime frame
1. Changes in the frequency of stress incontinence, any daytime incontinence, night-time incontinence, daytime voids in toilet, nighttime voids in toilet assessed by 3 days voiding diary. 2. Quality of life as measured by ICIQ-UI SF (International Consultation on Incontinence Modular Questionnaire-Urinary Incontinence) Short Form. Timepoint: Baseline, 4 weeks, 8 weeks;1.Cough stress test 2. Pad test 3. Uroflowmetry. 4.USGTimepoint: Baseline, 8 weeks

Countries

India

Contacts

Public ContactDr Jeyadeepa R

IPGMER and SSKM Hospital

bhowmikmala@gmail.com9735913451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026